BFIM
CVS icon

Beese Fulmer Investment Management’s CVS Health CVS Stock Holding History

Beese Fulmer Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Sell
2,076
-885
-30% -$79K 0.01% 367
2026
Q1 		$213K Sell
2,961
-817
-22% -$62.9K 0.01% 404
2025
Q4 		$300K Sell
3,778
-391
-9% -$30.8K 0.02% 290
2025
Q3 		$314K Sell
4,169
-4
-0.1% -$274 0.02% 230
2025
Q2 		$288K Buy
4,173
+100
+2% +$6.56K 0.02% 240
2025
Q1 		$276K Buy
+4,073
New +$244K 0.02% 207
2024
Q4 		– Sell
-3,946
Closed -$248K – 231
2024
Q3 		$248K Sell
3,946
-880
-18% -$51.3K 0.02% 204
2024
Q2 		$285K Sell
4,826
-854
-15% -$53.4K 0.03% 191
2024
Q1 		$453K Sell
5,680
-107,962
-95% -$8.25M 0.04% 150
2023
Q4 		$8.97M Sell
113,642
-8,496
-7% -$605K 0.93% 42
2023
Q3 		$8.53M Sell
122,138
-10,194
-8% -$722K 0.96% 39
2023
Q2 		$9.15M Sell
132,332
-498
-0.4% -$35.4K 0.99% 39
2023
Q1 		$9.87M Buy
132,830
+4,438
+3% +$372K 1.13% 32
2022
Q4 		$12M Buy
128,392
+4,319
+3% +$417K 1.44% 17
2022
Q3 		$11.8M Buy
124,073
+1,316
+1% +$130K 1.59% 18
2022
Q2 		$11.4M Buy
122,757
+724
+0.6% +$70.7K 1.46% 19
2022
Q1 		$12.4M Buy
122,033
+1,351
+1% +$142K 1.34% 22
2021
Q4 		$12.4M Buy
120,682
+3,631
+3% +$336K 1.3% 25
2021
Q3 		$9.93M Buy
117,051
+1,122
+1% +$94K 1.12% 27
2021
Q2 		$9.67M Buy
115,929
+3,711
+3% +$304K 1.09% 29
2021
Q1 		$8.44M Buy
112,218
+3,060
+3% +$223K 1.01% 33
2020
Q4 		$7.46M Sell
109,158
-486
-0.4% -$31.6K 0.95% 35
2020
Q3 		$6.4M Buy
109,644
+1,649
+2% +$103K 0.91% 37
2020
Q2 		$7.02M Buy
107,995
+7,533
+7% +$474K 1.03% 31
2020
Q1 		$5.96M Buy
100,462
+4,295
+4% +$287K 1.06% 31
2019
Q4 		$7.14M Buy
96,167
+5,975
+7% +$420K 1% 35
2019
Q3 		$5.69M Buy
90,192
+3,756
+4% +$223K 0.85% 42
2019
Q2 		$4.71M Buy
86,436
+2,183
+3% +$118K 0.89% 47
2019
Q1 		$4.54M Buy
84,253
+76,262
+954% +$4.71M 0.9% 49
2018
Q4 		$524K Buy
+7,991
New +$597K 0.12% 107

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Beese Fulmer Investment Management's CVS Position: Q2 2026 in Review

Beese Fulmer Investment Management reduced its CVS Health (CVS) stake by 30% in Q2 2026, selling an estimated $79K and leaving 2,076 shares worth $215K. The position accounts for 0.01% of the portfolio, ranked #367.

Beese Fulmer Investment Management first reported a position in CVS in Q4 2018 and has held it in 30 quarters since. The position peaked at $12.4M in Q4 2021. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Beese Fulmer Investment Management held 2,076 shares of CVS Health worth $215K as of Q2 2026.
  • Beese Fulmer Investment Management sold 885 CVS Health shares in Q2 2026, an estimated $79K.
  • CVS Health made up 0.01% of Beese Fulmer Investment Management's portfolio in Q2 2026, its #367 holding.
  • Beese Fulmer Investment Management first reported a position in CVS Health in Q4 2018 and has held it in 30 quarters since.
  • Beese Fulmer Investment Management's CVS Health position peaked at $12.4M in Q4 2021.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Beese Fulmer Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.